Truway Health Announces Release of the LUMEN‑HAB Protocol: A Multiphase Operational Study Advancing Human Habitation Beyond Earth
April 11, 2026 — Manhattan, NY
Truway Health, Inc. has formally released THI‑LUNAR‑GATEWAY‑MARS‑HAB‑001 (LUMEN‑HAB), a landmark multiphase operational protocol designed to evaluate the environmental, logistical, and systems‑level requirements for sustained human habitation on the lunar surface, within the Lunar Gateway transit architecture, and across Mars‑analog environments. The protocol is now publicly accessible through ClinicalTrials.gov.
LUMEN‑HAB represents a new class of operational research: a validator‑grade, telemetry‑driven, multi‑environment assessment that integrates habitat resilience testing, environmental control and life‑support system (ECLSS) continuity, radiation‑exposure modeling, EVA logistics, and long‑duration behavioral stability. The study’s central focus is the identification, extraction, processing, and utilization of lunar and Martian water‑ice resources to support life‑support functions, radiation shielding, and in‑situ propellant production.
“Human habitation beyond Earth demands more than engineering ambition — it requires a validated operational architecture capable of withstanding environmental volatility, resource constraints, and mission‑critical system failures,” said Gavin Solomon, President & CEO of Truway Health and Responsible Party for the study. “LUMEN‑HAB provides a structured, evidence‑driven framework for understanding how lunar and Martian environments can support sustained human presence.”
Although LUMEN‑HAB does not involve human subjects or biomedical interventions, the protocol adheres to federal registration standards and employs a rigorous methodology consistent with high‑fidelity operational research. The study incorporates acoustic telemetry arrays, neural‑state modeling, reactor‑interface signaling, and validator‑grade blockchain governance rails to ensure transparency, reproducibility, and operational integrity.
Key Objectives of LUMEN‑HAB
-
Evaluate habitat system resilience across lunar, Gateway, and Mars‑analog environments
-
Assess water‑ice extraction, processing, and conversion efficiency
-
Model radiation exposure and shielding performance
-
Analyze EVA logistics, dust mitigation, and mobility constraints
-
Measure life‑support continuity under stress conditions
-
Characterize behavioral stability during long‑duration isolation
-
Validate operational continuity across transit‑to‑surface mission phases
The findings from LUMEN‑HAB are expected to inform future mission architectures for lunar permanence, Gateway‑supported logistics, and accelerated readiness for Martian surface habitation. The protocol also establishes a foundation for coalition‑grade governance frameworks, enabling transparent, multi‑agency collaboration in the emerging domain of interplanetary habitation research.
The full protocol record is available under Unique Protocol ID: THI‑LUNAR‑GATEWAY‑MARS‑HAB‑001.
Truway Health News & Insights
3D Ultrasound vs. Traditional Ultrasound: What Is the Difference?
Introduction Ultrasound is one of the most widely used medical imaging technologies. It uses high-fr...
Autumn Healthcare Tips & Tricks: A Simple Guide to Staying Well This Season
As the leaves change, so do our routines. Autumn brings cooler temperatures, shorter days, changing...
TruWay Health Announces OMNIPHYS: A 20-Year Multimodal Physiologic State Intelligence Research Program
PRESS RELEASE TruWay Health Announces OMNIPHYS: A 20-Year Multimodal Physiologic State Intellige...
Truway Health Announces ClinicalTrials.gov Registration of 50-Year Prospective Study Examining “Clinical Time” and Temporal Dynamics in Patient Health
PRESS RELEASE Truway Health Announces ClinicalTrials.gov Registration of 50-Year Prospective...
TruWay Health Advances FUSION-72 Study to Investigate Multimodal Digital Biomarkers for Acute Deterioration
TruWay Health Advances FUSION-72 Study to Investigate Multimodal Digital Biomarkers for Acute Deteri...
Truway Health Releases TRU-OMNIBODY Whole-Body Digital Twin and Physiologic Resilience Study
FOR IMMEDIATE RELEASE Truway Health Releases TRU-OMNIBODY Whole-Body Digital Twin and Physiologic Re...